Maravai LifeSciences Holdings, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 65.8M | 49.9M | 41.6M | 47.4M | 46.9M | 56.4M | 65.2M | 73.4M |
| Cost of Goods Sold | 32.1M | 37.6M | 36.0M | 39.6M | 39.1M | 37.4M | 36.8M | 38.3M |
| Gross Profit | 33.7M | 12.2M | 5.7M | 7.8M | 7.7M | 19.0M | 28.4M | 35.1M |
| R&D Expenses | 3.9M | 3.8M | 9.8M | 4.9M | 4.9M | 4.6M | 4.3M | 5.3M |
| Operating Expenses | 31.2M | 19.0M | -109.8M | 74.0M | 56.9M | 57.1M | 197.5M | 44.6M |
| Operating Income | 2.5M | -6.7M | 115.4M | -66.3M | -49.2M | -38.1M | -169.1M | -9.5M |
| Other Income / Gains | -9.0M | -56.3M | -160.6M | -7.8M | -3.5M | -8.4M | -6.5M | -7.4M |
| Net Income | -3.7M | -35.7M | -25.6M | -39.6M | -29.9M | -26.1M | -99.0M | -7.6M |
| EPS (Diluted) | -0.026 | -0.25 | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.056 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.512 | 0.245 | 0.136 | 0.164 | 0.165 | 0.336 | 0.435 | 0.479 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 27.3M | 15.2M | 78.1M | 38.6M | 39.6M | 41.2M | 39.1M | 40.6M |
| Other Expenses | 0 | 0 | -197.7M | 30.6M | 12.4M | 11.3M | 154.1M | -1.2M |
| Cost And Expenses | 63.4M | 56.6M | -73.8M | 113.7M | 96.0M | 94.5M | 234.3M | 82.9M |
| Interest Income | 1.9M | 2.4M | 15.3M | 3.0M | 3.2M | 6.0M | 7.1M | 7.1M |
| Interest Expense | 5.7M | 6.6M | 6.8M | 6.8M | 6.8M | 11.3M | 13.6M | 11.9M |
| Depreciation And Amortization | 13.0M | 14.7M | 15.8M | 15.4M | 14.9M | 14.5M | 14.0M | 14.5M |
| Ebitda | 12.2M | -41.7M | -22.5M | -51.9M | -31.0M | -20.7M | -148.0M | 9.6M |
| Ebitdaratio | 0.185 | -0.837 | -0.54 | -1.096 | -0.662 | -0.367 | -2.269 | 0.13 |
| Operating Income Ratio | 0.038 | -0.135 | 2.773 | -1.398 | -1.049 | -0.676 | -2.594 | -0.13 |
| Income Before Tax | -6.5M | -63.0M | -45.1M | -74.1M | -52.7M | -46.5M | -175.6M | -16.9M |
| Income Before Tax Ratio | -0.099 | -1.264 | -1.085 | -1.564 | -1.125 | -0.824 | -2.694 | -0.231 |
| Income Tax Expense | -151K | 6K | -92K | -4.3M | 162K | -7K | 311K | -2.4M |
| Net Income Ratio | -0.057 | -0.716 | -0.614 | -0.835 | -0.639 | -0.464 | -1.519 | -0.103 |
| Epsdiluted | -0.026 | -0.25 | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.056 |
| Weighted Average Shs Out | 146.4M | 145.1M | 144.7M | 144.2M | 143.4M | 141.8M | 141.6M | 135.8M |
| Weighted Average Shs Out Dil | 146.4M | 145.1M | 144.7M | 144.2M | 143.4M | 139.7M | 141.6M | 135.8M |